Jt Stratford LLC Novavax Inc Transaction History

Jt Stratford LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$69.73 - $142.9 $253,817 - $520,156	-3,640 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$134.56 - $217.97 $54,496 - $88,277	-405 Reduced 10.01%	3,640 $521,000
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $45,161 - $68,727	254 Added 6.7%	4,045 $839,000
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $4,477 - $9,533	37 Added 0.99%	3,791 $805,000
Q1 2021 May 12, 2021	SELL	$112.98 - $319.93 $44,514 - $126,052	-394 Reduced 9.5%	3,754 $681,000
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $138,897 - $246,078	1,764 Added 73.99%	4,148 $463,000
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $189,384 - $425,567	2,384 New	2,384 $258,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Jt Stratford LLC, based on Form 13F filings with the SEC.

Stay updated on Jt Stratford LLC with notifications on news.